Lipidomics reveals immune-related adverse events in NSCLC patients receiving immune checkpoint inhibitor
Lipidomics reveals immune-related adverse events in NSCLC patients receiving immune checkpoint inhibitor is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Lipidomics reveals immune-related adverse events in NSCLC patients receiving immune checkpoint inhibitor have?
Lipidomics reveals immune-related adverse events in NSCLC patients receiving immune checkpoint inhibitor has 19 citations in the OpenAlex counts ScholarIQ stores.
When was Lipidomics reveals immune-related adverse events in NSCLC patients receiving immune checkpoint inhibitor published?
Lipidomics reveals immune-related adverse events in NSCLC patients receiving immune checkpoint inhibitor has 2023 year in the ScholarIQ index.
What is the open-access status of Lipidomics reveals immune-related adverse events in NSCLC patients receiving immune checkpoint inhibitor?
Lipidomics reveals immune-related adverse events in NSCLC patients receiving immune checkpoint inhibitor has closed oa status in the ScholarIQ index.
What is the DOI of Lipidomics reveals immune-related adverse events in NSCLC patients receiving immune checkpoint inhibitor?
The DOI for Lipidomics reveals immune-related adverse events in NSCLC patients receiving immune checkpoint inhibitor is on the source record.
What is the PMID of Lipidomics reveals immune-related adverse events in NSCLC patients receiving immune checkpoint inhibitor?
The PMID for Lipidomics reveals immune-related adverse events in NSCLC patients receiving immune checkpoint inhibitor is on the source record.
What is the OpenAlex record for Lipidomics reveals immune-related adverse events in NSCLC patients receiving immune checkpoint inhibitor?
The OpenAlex for Lipidomics reveals immune-related adverse events in NSCLC patients receiving immune checkpoint inhibitor is on the source record.